Giuseppe Lippi/LinkedIn
Oct 10, 2025, 03:09
Giuseppe Lippi: We Show Here That Red Light Therapy Offers Promise in High-Risk Patients
Giuseppe Lippi, Dean of Medicine at the University of Verona, shared on LinkedIn:
”We show here that red light therapy offers promise in high-risk patients where conventional anticoagulation is limited by bleeding risk.
Fan BE, Pasalic L, Lippi G, Hew YY, Favaloro EJ. Red Light Therapy in Thrombosis and Hemostasis. Semin Thromb Hemost. 2025 Oct 8. doi: 10.1055/a-2717-5157. Epub ahead of print.”
Read the full article in Seminars in Thrombosis and Hemostasis.
Article: Red Light Therapy in Thrombosis and Hemostasis
Authors: Bingwen Eugene Fan , Leonardo Pasalic, Giuseppe Lippi , Yu Yue Hew, Emmanuel J. Favaloro
Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Jun 21, 2026, 18:08Roberta Gualtierotti: Point-of-Care SPR Device for Rapid Detection of Anti-PEG Antibodies
-
Jun 21, 2026, 17:59Fakhrul Abedin Jon: Exploring Types of Brain Bleeding
-
Jun 21, 2026, 17:00Jeffrey Schnur: Advanced Treatment Strategies for Deep Vein Thrombosis and Pulmonary Embolism
-
Jun 21, 2026, 16:53Matteo Foschi: When Should We Restart Anticoagulation After a Breakthrough Ischemic Stroke?
-
Jun 21, 2026, 16:33Dua Asim: Efficacy and Safety of Rivaroxaban Plus Aspirin in PAD Patients
-
Jun 21, 2026, 16:21Early Gains in Stroke Knowledge With Stroke Riskometer – International Journal of Stroke
-
Jun 21, 2026, 16:12Cost Savings and Reduced Factor Consumption With Efanesoctocog Alfa – Blood Journals Portfolio
-
Jun 21, 2026, 15:59John Jaksich: Heparin and Anticoagulants – Chemistry, Biotechnology, and Manufacturing
-
Jun 21, 2026, 15:11Mishal Khan: Long-Term Mortality Trends and Demographic Disparities in Patients With PE and AF